Taken together, our findings indicate that in breast cancer patients, obesity enhances the activation of the FA/HIF‐1α/CCL2 axis in tumor tissues and the CCL2/CCR2/PPARα axis in adjacent adipose tissue. Here, CCL2 is linked to obesity disorder.